View Older Stories View More Recent Stories

Sep 3, 2014 11:39AM Roth Remains Positive on BioLineRx (BLRX); Dosing of BL-8040 Phase 1 Initiated

Sep 3, 2014 11:03AM Roth Lifts Price Target on Regeneron (REGN) to $422 Following ODYSSEY Phase III Updates

Sep 2, 2014 12:32PM Motorcar Parts of America (MPAA) Closes 2.4M Common Offering

Sep 2, 2014 11:21AM Roth Positive on Trina Solar (TSL) Following Yunnan Metallurgical New Energy Transaction

Sep 2, 2014 09:00AM Full FDA Approval of Keryx's (KERX) Zerenex Expected - Roth Capital

Aug 28, 2014 04:55PM EZchip Semiconductor (EZCH) Pulls Out of Two Analyst Events

Aug 28, 2014 11:11AM Interferon Therapy for HCV Still Expected Strong Amid Daklinza Approval - Roth (LGND) (BMY)

Aug 28, 2014 02:39AM MEDIGUS ANNOUNCES COMPLETION OF $11.1 MILLION PRIVATE PLACEMENT

Aug 27, 2014 04:32PM Roth Cuts PT, Makes Adjusts to Yingli Green Energy (YGE) Following Q2 Results, Outlook

Aug 27, 2014 09:26AM Roth Comments on Ligand (LGND) Following Approval of Promact sNDA (GSK)

Aug 27, 2014 07:58AM Roth Maintains Trina Solar (TSL) at 'Buy'; Light Q3 Outlook Will Hamper Stock, China Rebound Expected

Aug 27, 2014 07:31AM Motorcar Parts of America (MPAA) Prices Larger 2.4M Common Offering at $26/Share

Aug 25, 2014 09:29AM Pre-Open Stock Movers 8/25: (ITMN) (THI) (BKW) (LTM) Higher; (RGDO) (QIHU) (THOR) Lower (more...)

Aug 25, 2014 08:37AM UPDATE: Roth Capital Starts Bio Blast Pharma (ORPN) at Buy

Aug 25, 2014 06:47AM Roth Capital Starts xG Technology, Inc. (XGTI) at Buy

Aug 21, 2014 09:35AM Roth Capital Comments on BioLineRx (BLRX) Following NoA for BL-7010; Sees Additional Milestones Approaching

Aug 21, 2014 09:24AM Roth Capital Comments on Buy-Rated Galena (GALE) Following CEO Transition

Aug 21, 2014 06:58AM Roth Affirms JA Solar (JASO) at 'Buy' Following Q2 Results, Outlook; Still has Attractive Valuation, Opportunities

Aug 20, 2014 04:03PM Motorcar Parts of America, Inc. (MPAA) to Offer 2M Shares

Aug 20, 2014 06:43AM Roth Capital Downgrades RGS Energy (RGSE) to Neutral

Aug 19, 2014 10:24AM Roth Affirms Cytori (CYTX) at Buy Following BARDA Update

Aug 15, 2014 02:04PM Daqo New Energy (DQ) Could Win with New China PV Ban; Canadian Solar (CSIQ), Trina (TSL) Others on Losing End - Roth Capital

Aug 15, 2014 07:14AM Roth Lifts PT on Plug Power (PLUG) Following Q2 Results; Highlights Key Takeaways from the Quarter

Aug 14, 2014 10:57AM Roth Remains Positive on Ligand Pharma (LNGD) Following New Licensing Agreement with Avion Pharma

Aug 14, 2014 09:45AM Roth Affirms Rexahn (RNN) at 'Buy'; Comments on Q2 Results, Pipeline Update

Aug 13, 2014 06:47AM Roth Capital Encouraged by ReneSola's (SOL) Progress, but Sustainable Profits Need to be Demonstrated

Aug 12, 2014 03:23PM Roth Keeps Concert Pharma (CNCE) at Buy; Making Good Progress with Clinical Programs

Aug 12, 2014 11:10AM Roth Capital Affirms 'Sell' Rating on Dendreon (DNDN) Following Q2 Results; Comments on Debt Issue

Aug 12, 2014 08:57AM UTStarcom (UTSI) CFO Resigns, Replacement Named

Aug 11, 2014 04:15PM Energy Focus Closes Public Offering of Common Stock

Aug 11, 2014 03:34PM Roth Capital Comments on Regeneron (REGN) After EC Approves Eylea for DME Patients

Aug 11, 2014 07:52AM Roth Capital Starts IRadimed Corp (IRMD) at Buy

Aug 8, 2014 09:16AM Roth Capital Raises Target on SolarCity (SCTY) 22.5% Following Q2 Results

Aug 8, 2014 06:44AM Roth Capital Downgrades Alexza Pharma (ALXA) to Neutral

Aug 7, 2014 12:05PM Roth Maintains Keryx (KERX) at 'Buy' Following Q2 Results; Long-Term Study Data Still Looks Good

Aug 7, 2014 09:02AM Roth Capital Upgrades PowerSecure (POWR) to Buy

Aug 6, 2014 02:10PM New CEO Whitaker is Positive for Synta Pharma (SNTA); Roth Affirms at 'Buy' Following Q2 Results

Aug 6, 2014 12:38PM Roth Raises Target on Enphase (ENPH) 50% Following Q2 Results and Outlook

Aug 6, 2014 08:15AM Energy Focus Announces Pricing of Public Offering of Common Stock

Aug 5, 2014 12:29PM Roth Capital Comments on Regeneron (REGN) Following Q2 Results; Affirms 'Buy' Rating

Aug 4, 2014 02:24PM Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)

Aug 4, 2014 08:50AM Key Takeaways from Hydrogenics' (HYGS) Q2 Report

Aug 4, 2014 07:00AM AGTC Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 1, 2014 08:42AM Roth Capital Starts Sucampo Pharmaceuticals (SCMP) at Buy

Aug 1, 2014 06:38AM Roth Capital Starts Alcobra Ltd. (ADHD) at Buy

Jul 31, 2014 02:17PM Cytokinetics (CYTK) Valuation Remains Attractive Following Q2 Results - Roth

Jul 31, 2014 11:58AM Streetinsider.com's Hot Lunchtime Reads 07/31:(NQ) (TMUS) (TSLA) (AMCX) (MCUR)

Jul 31, 2014 11:03AM New CEO Encouraging, but Plenty of Problems Persist at Dendreon (DNDN) - Roth Capital

Jul 31, 2014 10:33AM Bio Blast Pharma (ORPN) IPO Opens, Trades Lower

Jul 30, 2014 02:15PM Maxwell (MXWL) Risk-Reward Favorable into Q2 Report on Recent Pullback, FY15 Bus Read Through

View More Recent Stories View Older Stories